D. Dunlop

发表

ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease.

T. Lister, R. Gupta, Jenny C. Chang, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer

H. Wakelee, D. Dunlop, R. Ramlau, 2012, Cancer Chemotherapy and Pharmacology.

Overcoming CYP1A1/1A2 mediated induction of metabolism by escalating erlotinib dose in current smokers.

D. Dunlop, A. Price, M. Nicolson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combination therapy with gefitinib and rofecoxib in patients with platinum-pretreated relapsed non small-cell lung cancer.

D. Carbone, D. Dunlop, M. Ranson, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer

C. McArdle, D. Dunlop, D. McMillan, 2004, British Journal of Cancer.

S85 British Thoracic Oncology Group Trial, BTOG2: Randomised phase III clinical trial of gemcitabine combined with cisplatin 50 mg/m2 (GC50) vs cisplatin 80 mg/m2 (GC80) vs carboplatin AUC 6 (GCb6) in advanced NSCLC

D. Dunlop, K. O'Byrne, L. Billingham, 2011, Thorax.

A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study.

D. Dunlop, Ranjit V Thomas, Peter R. E. Johnson, 2003, Haematologica.

Phase II trial of the oral platinum complex JM216 in non-small-cell lung cancer: an EORTC early clinical studies group investigation.

D. Dunlop, J. Smyth, T. Cerny, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Bioavailability of subcutaneous 5-fluorouracil: a case report

D. Dunlop, D. Watson, M. Soukop, 1996, Cancer Chemotherapy and Pharmacology.

A Cost-Effectiveness Analysis of Docetaxel in the Second-Line Treatment of Non-Small Cell Lung Cancer

D. Dunlop, P. Sharplin, J. Holmes, 2012, PharmacoEconomics.

Randomized multicentre trial of filgrastim as an adjunct to combination chemotherapy for Hodgkin's disease. West of Scotland Lymphoma Group.

N. Lucie, D. Dunlop, W. Steward, 1998, Clinical oncology (Royal College of Radiologists (Great Britain)).

Phase I/II study of gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results.

D. Dunlop, D. Talbot, W. Steward, 1996, Seminars in oncology.

Primary mediastinal germ cell tumour and acute monocytic leukaemia occurring concurrently in a 15-year-old boy.

D. Dunlop, S. Kaye, P. Vasey, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Non-infusional 5-fluorouracil, doxorubicin and cisplatin in the treatment of locally advanced or metastatic gastro-oesophageal adenocarcinoma.

D. Dunlop, G. Pentheroudakis, M. Soukop, 2001, Acta oncologica.

Metastatic extragonadal seminoma associated with cardiac transplantation.

D. Dunlop, J. A. Fraser, M. Soukop, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

DHA-Paclitaxel (Taxoprexin) as First-Line Treatment in Patients with Stage IIIB or IV Non-small Cell Lung Cancer: Report of a Phase II Open-Label Multicenter Trial

P. Ellis, D. Dunlop, M. Ranson, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Primary Retroperitoneal Choriocarcinoma with Pulmonary Metastases in an Elderly Man

D. Dunlop, M. Soukop, V. Raina, 1990, Scottish medical journal.

A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1).

N Thatcher, R. Booton, D. Dunlop, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of imatinib in patients with small cell lung cancer.

D. Dunlop, R. Salgia, C. Fletcher, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer.

G. Giaccone, D. Dunlop, J. Nemunaitis, 2015, European journal of cancer.

Spontaneous regression of an anaplastic large cell lymphoma in the oral cavity: first reported case and review of the literature.

D. Dunlop, E. Fitzsimons, J. Gibson, 1999, Oral oncology.

Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer

D C McMillan, C. McArdle, D. Dunlop, 2003, British Journal of Cancer.

Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors.

D. Dunlop, J. von Pawel, U. Gatzemeier, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer

D. Dunlop, K. O'Byrne, L. Billingham, 2017 .

An alternating chemotherapy combination (macoble) for intermediate and high‐grade non‐hodgkin's lymphoma

D. Dunlop, J. Paul, M. Harding, 2006, Hematological oncology.

Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphoma.

D. Dunlop, C. Fegan, D. Cunningham, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer

C. McArdle, D. Dunlop, D. McMillan, 2005, British Journal of Cancer.

Extrapulmonary small cell carcinoma of bone.

D. Dunlop, R. Milroy, M. Soukop, 1992, Postgraduate medical journal.

Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer

D. Dunlop, D. Cameron, A. Price, 2005, British Journal of Cancer.

A phase II study of oxaliplatin and gemcitabine in advanced inoperable stage IIIB/IV non-small cell lung cancer.

D. Dunlop, J. Graham, J. Paul, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

S87 Delivered dose intensity of gemcitabine 1250 mg/m2 with cisplatin at 80 mg/m2 (GC80) and 50 mg/m2 (GC50) and carboplatin AUC 6 (GCb6) in a phase III trial of advanced non-small cell lung cancer (NSCLC): correlations with clinical outcomes

D. Dunlop, K. O'Byrne, L. Billingham, 2011, Thorax.

S86 Quality of life in advanced non-small cell lung cancer, effects of cisplatin dose and carboplatin in combination with gemcitabine: results from BTOG2, a British Thoracic Oncology Group phase III trial in 1363 patients

D. Dunlop, K. O'Byrne, M. Nicolson, 2011, Thorax.

Antenatal administration of aminopropylidene diphosphonate.

D. Dunlop, H. McEwan, M. Soukop, 1990, Annals of the rheumatic diseases.

CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity.

D. Dunlop, T. Holyoake, W. Steward, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1 alpha in vivo.

D. Dunlop, T. Holyoake, E. Wright, 1992, Blood.

Colonic adenocarcinoma associated ectopic ACTH secretion: a case history.

J. Connell, D. Dunlop, S. Kaye, 1995, European journal of cancer.

Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial

D. Dunlop, K. O'Byrne, L. Billingham, 2017, European journal of cancer.

Combination chemotherapy with gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results of an ongoing phase I/II study

D. Dunlop, D. Talbot, W. Steward, 1995, Anti-cancer drugs.